Literature DB >> 19740077

Why do phosphatidylinositol kinases have so many isoforms?

Sang H Min1, Charles S Abrams.   

Abstract

Macromolecules can be transported into the cells by endocytosis, either by phagocytosis or by pinocytosis. Typically, phagocytosis involves the uptake of solid large particles mediated by cell-surface receptors, whereas pinocytosis takes up fluid and solutes. The synthesis of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 plays fundamental roles in all forms of endocytosis. Curiously, almost all eukaryotic cells have multiple isoforms of the kinases that synthesize these critical phosphatidylinositols. In this issue of the Biochemical Journal, Namiko Tamura, Osamu Hazeki and co-workers report that the subunit p110alpha of the type I PI3K (phosphoinositide 3-kinase) is implicated in the phagocytosis and the pinocytosis of large molecules, whereas the receptor-mediated pinocytosis and micropinocytosis of small molecules do not seem to be controlled by this mechanism. The present commentary discusses recent literature that has begun to unravel why cells need so many phosphatidylinositol kinase isoforms, which were previously believed to be redundant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740077     DOI: 10.1042/BJ20091274

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  4 in total

1.  Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.

Authors:  Sarah E M Herman; Amber L Gordon; Amy J Wagner; Nyla A Heerema; Weiqiang Zhao; Joseph M Flynn; Jeffrey Jones; Leslie Andritsos; Kamal D Puri; Brian J Lannutti; Neill A Giese; Xiaoli Zhang; Lai Wei; John C Byrd; Amy J Johnson
Journal:  Blood       Date:  2010-06-03       Impact factor: 22.113

Review 2.  Molecular pathways: targeting phosphoinositide 3-kinase p110-delta in chronic lymphocytic leukemia.

Authors:  Sarah E M Herman; Amy J Johnson
Journal:  Clin Cancer Res       Date:  2012-06-18       Impact factor: 12.531

3.  Phosphatidylinositol-4-phosphate 5-kinases and phosphatidylinositol 4,5-bisphosphate synthesis in the brain.

Authors:  Laura A Volpicelli-Daley; Louise Lucast; Liang-Wei Gong; Lijuan Liu; Junko Sasaki; Takehiko Sasaki; Charles S Abrams; Yasunori Kanaho; Pietro De Camilli
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

4.  Platelets lacking PIP5KIγ have normal integrin activation but impaired cytoskeletal-membrane integrity and adhesion.

Authors:  Yanfeng Wang; Liang Zhao; Aae Suzuki; Lurong Lian; Sang H Min; Ziqian Wang; Rustem I Litvinov; Timothy J Stalker; Tadayuki Yago; Arkadiusz G Klopocki; David W Schmidtke; Helen Yin; John K Choi; Rodger P McEver; John W Weisel; John H Hartwig; Charles S Abrams
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.